Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kyle Malady Insider Profile
4 Followers
Kyle Malady, EVP and Group CEO-VZ Business at Verizon, holds 82.93K shares in Verizon (Ticker: VZ), holds 15.53K shares in Dexcom (Ticker: DXCM).
Kyle Malady Verizon (VZ)EVP and Group CEO-VZ Business
Verizon (VZ)
EVP and Group CEO-VZ Business
Ranked #51,786 out of 98,564 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-2.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kyle Malady holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kyle Malady
Kyle Malady's Trading History
Verizon
Mar 05, 2024
EVP and Group CEO-VZ Business
Uninformative Buy
1.32M
$3.29M
Dexcom
May 22, 2023
Director
Uninformative Buy
―
$1.93M
List of latest transactions for each holding click on a transaction to see Kyle Malady's performance on stock
You May Also Like
Kyle Malady insider profile FAQ
What is the percentage of profitable transactions made by Kyle Malady?
The percentage of profitable transactions made by Kyle Malady is 0%.
What is the average return per transaction made by Kyle Malady?
The average return per transaction made by Kyle Malady is -2.50%.
What stocks does Kyle Malady hold?
Kyle Malady holds: VZ, DXCM stocks.
What was Kyle Malady’s latest transaction?
Kyle Malady latest transaction was an Uninformative Buy of $1.32M.
What was Kyle Malady's most profitable transaction?
Kyle Malady’s most profitable transaction was an Informative Sell of VZ stock on February 20, 2024. The return on the trade was -1.50%.
What is Kyle Malady's role in Verizon?
Kyle Malady's role in Verizon is EVP and Group CEO-VZ Business.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.